Objective: To determine the distribution of endotracheally administered surfactant at the alveolar level in an animal model of acute respiratory distress syndrome. Design: Prospective, randomized animal study. Setting: Research laboratory of a university hospital. Subjects: Seventy-one male Sprague-Dawley rats, weighing 330 -370 g. Interventions: To measure surfactant distribution in vitro, a glass trough mimicking dichotomic lung anatomy was used to determine the spreading properties of bovine lung surfactant extract supplemented with fluorescent Bodipy-labeled surfactant protein B. To measure surfactant distribution in vivo, rats were anesthetized, and lipopolysaccharide was aerosolized (12 mg/kg body weight) to induce lung injury resembling acute respiratory distress syndrome; in control rats, buffered saline was aerosolized. Twenty-four hours later rats were anesthetized, tracheotomized, and mechanically ventilated (peak airway pressure ‫؍‬ 20 mbar; positive end-expiratory pressure ‫؍‬ 6 mbar; inspiration time ‫؍‬ expiration time ‫؍‬ 0.6 sec; FIO 2 ‫؍‬ 50%). Surfactant (bovine lung surfactant extract, supplemented with fluorescent Bodipy-labeled surfactant protein B; 50 mg/kg body weight) was applied as a bolus; in control rats, saline was administered as a bolus. Rats were ventilated for 5, 15, 30, or 60 mins (n ‫؍‬ 8 or 9 for each group). Then, lungs were excised and sliced. Lung slices, divided into aerated (open), underinflated (dystelectatic), or collapsed (atelectatic) alveolar areas, were examined by both light and fluorescence microscopy. Results: In vitro experiments revealed that surfactant spread independent of glass trough geometry and lowered the surface tension to equilibrium values (25 mN/m) within a few seconds. In vivo experiments showed that administered surfactant distributed preferentially into underinflated and aerated alveolar areas. Furthermore, surfactant distribution was not affected by length of mechanical ventilation. Conclusions: When conventional mechanical ventilation was used in lipopolysaccharide-induced lung injury, surfactant preferentially distributed into underinflated and aerated alveolar areas. Because surfactant rarely reached collapsed alveolar areas, methods aiding in alveolar recruitment (e.g., open lung concept or body positioning) should precede surfactant administration. (Crit Care Med 2002; 30:1083-1090) KEY WORDS: acute respiratory distress syndrome; alveolar distribution; fluorescence; surfactant protein B; surfactant replacement therapy; spreading
ulmonary surfactant is a mixture of lipids and proteins, synthesized and secreted by the alveolar type II epithelial cells. Its main function is to reduce the surface tension at the air/liquid interface of the lung by formation of a surface-active film. The presence of surfactant prevents the alveoli from collapsing at endexpiration and makes breathing with minimal effort possible. In addition, lung surfactant plays a substantial role in the lung's host defense system. An important component of lung surfactant is the small hydrophobic surfactant protein (SP)-B. This dimeric protein, which is closely associated with surfactant phospholipids, enhances lipid insertion into the monolayer at the air/liquid interface and influences the molecular ordering of the phospholipid monolayer (see Refs. 1 and 2 for reviews). The observation that homozygous SP-B knockout mice died of respiratory failure immediately after birth (see Ref. 3 for review) emphasizes the importance of SP-B. Moreover, blocking of SP-B with monoclonal antibodies in immature newborn rabbits led to respiratory failure and loss of surfactant activity (4) .
In premature newborns, a deficiency of surfactant is the primary cause of neonatal respiratory distress syndrome. Therefore, these infants are treated with exogenous surfactant, which dramatically decreases mortality rate (see Ref. 5 for review). In adult patients with acute lung injury, secondary changes in the endog-enous surfactant system have been found: The amount of surfactant-specific proteins in bronchoalveolar lavage (BAL) was considerably reduced, the total amount and composition of phospholipids in BAL were altered, and the biophysical activity of surfactant lavaged from lungs of patients with acute respiratory distress syndrome (ARDS) was decreased compared with that of healthy persons (6 -8) . These surfactant alterations are thought to contribute to ARDS. Therefore, also in adult patients, administration of exogenous surfactant has been suggested as a beneficial therapeutic strategy (9) .
The results obtained thus far with surfactant replacement therapy in ARDS patients are inconclusive. In an earlier series of clinical investigations, lung function and mortality rate remained largely unchanged (10, 11) . A more recent series of clinical investigations showed that gas exchange improved more than two-fold after surfactant instillation, but the effect was lost within a few hours and a repeat dose of surfactant was required to improve gas exchange again (12) . Furthermore, it was found that mortality rate decreased significantly after repetitive doses of natural surfactant (13) . Yet, others found (14) that neither gas exchange improved nor survival rate increased when a synthetic surfactant devoid of proteins was administered. The causes of these contradicting results are the subject of discussion (15, 16) .
Although the distribution of exogenous surfactant in ARDS models has been investigated before (17) (18) (19) (20) (21) , the tracer used was never labeled covalently to a surfactant protein. Furthermore, global (lobar) rather than local (alveolar) distribution was studied. Therefore, the aim of this study was to determine the distribution of endotracheally administered surfactant at the alveolar level in a rat model of ARDS caused by exposure to lipopolysaccharide (LPS) aerosols (22) .
MATERIALS AND METHODS

Materials
1,2-dipalmitoyl-sn-glycero-3-phosphocholine and 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) were obtained from Avanti Polar Lipids (Alabaster, AL). Methanol (MeOH; Scharlau, Barcelona, Spain), chloroform (B&J, Miskegon, MI), dimethylsulfoxide (Sigma Chemical, St. Louis, MO), and butanol and triethylamine (Fluka, Buchs, Switzerland) were high-performance liquid chromatography grade. N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3propionyl)cysteic acid succinimidyl ester (Bodipy FL CASE, lot no. 4481-1) was obtained from Molecular Probes Europe (Leiden, The Netherlands). N-hydroxyethylpiperazine-N-2ethane sulfonic acid, KCl, NaCl, phosphatebuffered saline, and EDTA were obtained from Sigma Chemical. Water was filter purified (Modulab Water Systems, Lowell, MA). Agarose (SeaKem ME agarose; FMC Bioproducts, Rockland, ME) was extracted as described (23) . Alveofact was purchased from Thomae (Biberach, Germany).
SP-B was isolated from bovine bronchoalveolar lavage fluid. Bovine lungs were obtained from a slaughterhouse, and isolation and characterization of SP-B were performed as described by Oosterlaken-Dijksterhuis et al. (24) . Bovine lung surfactant extract (BLSE; containing surfactant lipids, SP-B and SP-C) is obtained during a step of this SP-B isolation procedure. The amount of protein was determined according to Böhlen et al. (25) , by using bovine serum albumin as standard. The amount of phospholipids was determined according to Rouser et al. (26) .
Fluorescent Labeling of SP-B
Bovine lung surfactant extract was supplemented with Bodipy-labeled SP-B as a marker for surfactant distribution. SP-B was considered an ideal marker because SP-B is a natural component of surfactant and SP-B is a prerequisite for a properly functioning surfactant system. Labeling of SP-B with Bodipy FL CASE and full characterization of Bodipy-labeled SP-B are described elsewhere (27) . In short, a 770-fold molar excess of triethanolamine and a 16fold molar excess of Bodipy FL CASE were added to 50 g of purified bovine SP-B dissolved in dimethylsulfoxide. After 30 mins of incubation, the reaction products were separated by reverse-phase HPLC. Bodipylabeled SP-B closely resembled native SP-B in both structure and biophysical activity.
Captive Bubble Surfactometer
Important biophysical variables to verify constant quality of a surfactant preparation can be obtained in a captive bubble surfactometer (28) . Therefore, in parallel to the in vivo experiments, quality control experiments were performed with freeze-dried BLSE. Captive bubble surfactometer experiments were done with adsorbed films (1 mg of phospholipid per 1 mL of saline, n ϭ 12). The area of a 20-L air bubble was increased by a sudden lowering of the pressure from 1.0 to 0.5 bar to study adsorption. After 1 min, the pressure was stepwise increased to 2.8 bar, where it was kept constant for 5 mins to determine film stability. Then, the bubble was cycled nine times within 2 mins between two preset pressure values of 0.5 and 2.8 bar to measure surface activity of the film during dynamic cyclic area changes. Alveofact suspensions (bovine lung surfactant extract, 1 mg phospholipid/mL) were used as a control.
In Vitro Distribution: Lung Spreading Trough
The ability of surfactant to spread in the lung as a function of geometry was determined in a spreading trough (custom-made by Swarovski, Wattens, Austria), which is a twodimensional anatomical replica of the first three generations of a human lung's tracheobronchial tree (Fig. 1 ). The trough was filled with subphase buffer (140 mM NaCl, 10 mM N-hydroxyethylpiperazine-N-2-ethane sulfonic acid, 0.5 mM EDTA, 2.5 mM CaCl 2 , pH 6.9) and covered with a Plexiglas lid to maintain humidity near saturation at 37°C. At the tracheal position of the trough, just underneath the buffer surface, a 1% (w/v) agarose slab (3-4 mm thick, position a) was placed to serve as a ramp for the surfactant sample. In the lid, four holes were drilled (18 ϫ 5 mm) through which roughened platinum plates were dipped into the buffer. Each plate was connected to a force-displacement transducer (FT 03; Grass, Quincy, MA) to measure surface tension (Wilhelmy plate technique). After droplet formation (multichannel pipettor), the sample was gently applied onto the buffer surface. The moment that the surface tension measured at position a had reached 65 mN/m (from 69.9 mN/m) was taken as the starting point of the experiment. Lung surfactant spreading was defined as the surface tension reached at positions b, c or d within 5 secs after sample application.
Multilamellar vesicles of BLSE supplemented with native or Bodipy-labeled SP-B were prepared as follows: 58 g of SP-B was mixed with BLSE (1250 g on phospholipid basis) in butanol, and a double volume of water was added subsequently. After vigorous mixing on a vortex mixer, the sample was instantaneously frozen in liquid nitrogen, freeze-dried overnight, and stored at Ϫ20°C. On the day of a spreading experiment, freezedried surfactant was suspended in saline to a final concentration of 41.7 mg phospholipid/ mL.
In Vivo Distribution: Animal Experimental Design
Animals. Male albino Sprague-Dawley rats (Him:OFA/SPF) obtained from the Forschungsinstitut für Versuchstierzucht und -haltung (University of Vienna, Himberg, Austria) were housed in Macrolon cages on dust-free pine shavings. Until treatment, the rats (330 -370 g) were kept at a regular 12-hr light/dark cycle with a temperature of 22 Ϯ 2°C. Food (Altromin1324ff, Lage, Germany) and acidified water were given ad libitum. Animal studies were approved by both the Committee for Animal Experiments of the University of Innsbruck and the Austrian Ministry for Science and Traffic (permission GZ66.011/82-Pr/4/98). Care and handling of animals were in accord with National Institutes of Health guidelines.
Preparation of Aerosols for Induction of Lung Injury. Lung injury induced by intratracheal aerosolization of LPS causes lung damage with a clinical picture comparable to that of ARDS in human patients (22) . LPS from Salmonella enteritidis obtained from Sigma Chemical (lot no. 55F4013) was dissolved in LPS-free phosphate-buffered saline at pH 7.4. For aerosolization, a miniature nebulizer (PennCentury, Philadelphia, PA) consisting of a 0.5 mL syringe (1750 TLL Hamilton, Bonaduz, Switzerland) in combination with a nozzle mounted on top of a stainless steel tube (length 5.5 cm, diameter 1 mm) was used. This nebulizer allows aerosolization of a small volume (0.2 mL).
Anesthesia and Induction of Lung Injury. Rats were anaesthetized by inhalation of ether vapor. With the rat fixed in supine position, the trachea was intubated with the aerosolizer tube and LPS (12 mg/kg) was aerosolized in the trachea just above the bifurcation. Subsequently, the rats were housed in their cages.
Anesthesia, Surgical Procedures, and Mechanical Ventilation. Rats were anesthetized by ketamine (100 mg/kg intramuscularly; Ketasol, Gräub, Berne, Switzerland) and xylazine (7 mg/kg intramuscularly; Rompun, Bayer, Leverkusen, Germany). Respiratory frequency was determined from radiologic observation of chest movements during a 30-sec period. After tracheotomy, rats were intubated with a homemade steel tube (12 mm length, 1 mm diameter). Neuromuscular blockade was induced by pancuronium bromide (0.6 mg/kg injected into the tail vein; Pavulon, Organon Teknika, Boxtel, The Netherlands), and pressure controlled mechanical ventilation was initiated (peak airway pressure ϭ 20 mbar; positive end-expiratory pressure ϭ 6 mbar; inspiration time ϭ expiration time ϭ 0.6 sec; FIO 2 ϭ 50%; Babylog 8000, Dräger, Austria) in supine position. Either two or four rats were ventilated simultaneously, always evenly divided between LPS treatment and control. For blood gas analysis, a catheter (polyethylene, 0.9 mm diameter) was inserted into the carotid artery, and 12.5 IU of heparin (Immuno, Vienna, Austria) was injected. Blood was analyzed by using an AVL 995 automatic blood gas system and an AVL 912 CO-Oxylite (AVL Medical Instruments, Graz, Austria).
Computed Tomography (CT). CT scans (1 mm slice thickness) were recorded by a Hi-Speed Advantage (General Electric Medical Systems, Milwaukee, WI) at 120 kV and 200 mA by using a computational lung algorithm.
Compliance. A volume-pressure diagram was recorded by using a homemade pressure-driven hydraulic piston (pressure sensor range 0 -200 mbar). While rats were kept in deep anesthesia and full muscle relaxation, their lungs were inflated with 100% oxygen in steps of 0.5 mL until a pressure of 25 mbar was reached; subsequently, the lungs were deflated in 0.5 mL steps. The time typically required for a full inflation-deflation cycle was 35-40 secs. Airway pressure was measured continuously. Compliance was defined as the volume of oxygen insufflated at a pressure of 25 mbar.
Surfactant Administration. To study the distribution of exogenously administered surfactant, BLSE (50 mg phospholipid/kg body weight) supplemented with Bodipy-labeled SP-B (143 g/kg, approximately one-fourth of the endogenous amount) was instilled as a bolus (0.5 mL in saline) into the trachea just above the bifurcation.
General Experimental Protocol. On day 1, rats were anesthetized and LPS was aerosolized intratracheally. In control rats, phosphate-buffered saline was aerosolized instead of LPS. On day 2, 24 hrs after the induction of lung injury, rats were anaesthetized with ketamine/xylazine and lung CT scans were recorded. After tracheotomy was performed and mechanical ventilation was initiated, a blood sample (0.5 mL) was withdrawn from the carotid artery and lung compliance was measured. Then, BLSE supplemented with Bodipy-labeled SP-B was administered. To facilitate surfactant spreading into underinflated and collapsed alveolar areas, lungs were inflated three times to 20 mbar for 3-sec periods after surfactant administration. Subsequently, the rats were mechanically ventilated for 5, 15, 30, or 60 mins (n ϭ 8 rats per group). Subsequently, the chest was opened and the rat lungs were excised. In control rats, saline was administered instead of surfactant.
Histology and Microscopy. The excised lungs were fixed for 12 hrs at atmospheric pressure in fixation buffer (2% w/v paraformaldehyde and 10% w/v sucrose in 0.1 M Na-phosphate, pH 7.35) at room temperature. Subsequently, the lungs were washed overnight in sucrose buffer (30% w/v sucrose in 0.1 M Na-phosphate, pH 7.35) at 4°C. Lungs were stored at Ϫ20°C in Tissue-Tek OCT Compound (Sakura, Zoeterwoude, The Netherlands) until use. Each left lung was cut vertically into four equal pieces, at approximately one-fourth, one-half, and three-fourths of the ventral-to-dorsal distance. Then, each piece was further sliced longitudinally (10 m thickness) by using a Frigocut 2800 cryostatic microtome (Reichert-Jung, Vienna, Austria), with the chamber at Ϫ25°C and the cutting block at Ϫ17°C. One of two successive slices was hematoxylin-eosin stained. The other slice was covered with a droplet of Vectashield H-1000 mounting medium (Vector Laboratories, Burlingame, CA) to prevent fluorescence photobleaching. Slices were examined by both light microscopy and fluorescence microscopy (Polyvar, Reichert-Jung; fluorescence excitation filter 455-490 nm, dichroic mirror 500 nm, emission filter 515 nm) at ϫ400 magnification. To determine the accuracy of an eyebased classification of lung areas (open, dystelectatic, or atelectatic), photos of 281 slices were taken on PAN F 50 film (Ilford Imaging, Dreieich, Germany), and the tissue/air ratios (black/white ratio of the photo films) were determined by using Photoshop version 3.0 (Adobe Systems, San Jose, CA). For statistical analysis of the distribution of Bodipy-labeled SP-B, slices were randomly chosen and examined by fluorescence microscopy. Each slice was divided into open (aerated), dystelectatic (underinflated), and atelectatic (collapsed) alveolar areas, as judged by eye. Next, a 100-cell counting grid was inserted. Then, ten atelectatic, ten dystelectatic, and ten open lung areas were randomly selected, and the number of grid cells containing a fluorescence signal was counted. In case the area of interest contained airway structures or blood vessel, the counting grid was moved to a different position. To see if administered surfactant distributed preferentially into specific areas, the number of grid-cells containing fluorescent signals in a given alveolar area was standardized for the presence of air and tissue. This was done by dividing this number by the tissue/air ratio of that respective area.
Bronchoalveolar Lavage. Rat lungs were lavaged by using six volumes of 10 mL saline. BAL fluid was centrifuged (142 g, 10 mins, 4°C), and the supernatant was taken for determination of total protein by Pierce Micro BCA assay by using bovine serum albumin as standard. BAL pellet was resuspended in saline, and aliquots were cytocentrifuged and stained with May-Grünwald and Giemsa solution (Merck, Darmstadt, Germany) for cell count. Three hundred cells were counted, and the percentage of present alveolar macrophages, lymphocytes, and polymorphonuclear neutrophils was determined.
Thin Layer Chromatography. Thin layer chromatography was performed according to Touchstone et al. (29) to check for lipid degradation of BLSE during storage. The amount of lipid phosphorus in thin layer chromatography spots was determined according to Bartlett (30) .
Statistics
For statistical analysis, the computer program SPSS version 9.0 was used (SPSS, Chicago, IL). Data were compared by analysis of variance with Bonferroni post hoc test, Mann-Whitney test, or Kruskal-Wallis test as indicated. Differences were considered significant at p Ͻ .05.
RESULTS
BLSE Quality Control
Throughout the in vivo experiments (90 days), BLSE was stored at Ϫ20°C
until use and aliquots were tested repeatedly for material deterioration. No changes in phospholipid composition were found by thin layer chromatography (Table 1 ; n ϭ 4 experiments). Furthermore, the surface activity, tested in a captive bubble surfactometer (n ϭ 12), showed no differences with regard to film formation as well as minimum and maximum surface tension reached during cycling. Similarly, the spreading properties, tested in a square glass tray (n ϭ 9; for method see Ref. 27 ), remained unchanged.
In Vitro Distribution of Fluorescently Labeled Surfactant
A spreading trough was used to test whether spreading of surfactant throughout the first three generations of the airway depended on geometry. It was found that the surface tension reached 5 secs after sample application to the buffer surface was the same at positions a, b, c and d for each surfactant tested (Table 2) . Moreover, when comparing the surfactant mixtures we found that the final surface tensions reached at positions a, b, c, and d by BLSE and Alveofact (both containing SP-B and SP-C) were equally low at 26 mN/m (p ϭ 1.0). BLSE supplemented with Bodipy-labeled SP-B also was able to lower the surface tension to a comparably low value. In a subsequent series of experiments, BLSE was spread on buffer to which bovine serum albumin had been added (10 mg/mL). This protein concentration is similar to that found in ARDS patients: 0.5-4 mg/mL in BAL fluid (31-33) and 12 mg/mL in alveolar epithelial lining fluid (31) (the protein concentration in BAL fluid of healthy persons is around 0.1 mg/mL). The surface tension reached 5 secs after sample application did not differ between bovine serum albumin containing buffer and buffer alone. This shows that administered surfactant is able to spread on an aqueous surface even when a plasma protein is present at a concentration similar to that found in ARDS patients. In another set of experiments where multilamellar vesicles consisting solely of lipids were applied to the buffer surface, the need of surfactant proteins for surfactant spreading was shown. These lipid multilamellar vesicles were not able to spread a film, as indicated by the absence of a decrease in surface tension. In contrast, when SP-B or Bodipy-labeled SP-B was added to these multilamellar vesicles, surface tension decreased by approximately 20 mN/m. From these results we concluded that both BLSE and Alveofact were able to quickly cover the entire air/water interface and lower the surface tension independent of airway branching. Furthermore, we concluded that in vitro spreading of BLSE was not impaired by supplementation with Bodipy-labeled SP-B. Therefore, this fluorescently labeled surfactant could be used to follow its distribution in vivo. No statistically significant difference among these three surfactants was found by means of analysis of variance (ANOVA); c p Ͻ .01 for BLSE supplemented with Bodipy-labeled SP-B vs. all other surfactants by means of ANOVA; d Significantly different from all other surfactants (p Ͻ .001) by means of ANOVA; e No statistically significant difference was found between both surfactants, but each was significantly different from all other surfactants (p Ͻ .001) by means of ANOVA.
In Vivo Distribution of Fluorescently Labeled Surfactant
Development of ARDS in Rats. LPS exposure to rats resulted in lung damage ( Table 3 ). Measurements of total protein concentration and differential cell count in BAL showed that proteinaceous edema and inflammation had occurred. Furthermore, in LPS-exposed rats, respiratory frequency was higher (p Ͻ .05) and compliance was lower (p Ͻ .001) than in control rats, and both arterial oxygenation and ventilation were impaired (p Ͻ .001). CT scans of the chest revealed that LPS exposure caused formation of lung edema and dense areas. The left lung generally was found to be more affected than the right lung (Fig. 2) . These findings were confirmed by histologic evaluation of hematoxylin-eosin stained lung slices, which showed a high percentage of atelectatic and dystelectatic regions (40% to 90% of total lung area analyzed), a high content of polymorphonuclear infiltrates, thickening of the alveolar-capillary membrane, and accumulation of erythrocytes outside larger pulmonary blood vessels. In contrast, histologic evaluation of control lungs showed little atelectatic and dystelectatic regions, no polymorphonuclear infiltration, and neither thickening of the alveolar-capillary membrane nor accumulation of erythrocytes outside blood vessels.
Surfactant Distribution. Analysis of lung slices by light microscopy showed that mean tissue/air ratios were different for aerated (open), underinflated (dystelectatic), and collapsed (atelectatic) areas (0.5, 1.0, and 1.5, respectively; p Ͻ .001 by means of Kruskal-Wallis test), confirming that judgment of lung tissue by eye according to these categories was legitimate. A hematoxylineosin-stained lung slice of an LPSexposed rat showing the different lung tissue aeration states is depicted in Figure 3 .
For LPS-exposed and surfactanttreated rats, the number of grid cells containing a fluorescent signal was independent of the ventral-to-dorsal distance (data not shown) but dependent on type of alveolar area. When slices were examined microscopically, fluorescent signals were predominantly seen in dystelectatic areas and to a lesser extent in open lung areas (Fig. 4) . They rarely were seen in atelectatic areas. This observation was confirmed statistically when the number of grid cells containing fluorescence per alveolar area was expressed as a function of lung tissue aeration (Fig. 5, p Ͻ .001) . The number of grid cells containing a fluorescent signal was not significantly different among the four periods of mechanical ventilation (5, 15, 30 , and 60 mins) studied.
DISCUSSION
The aim of this study was to follow the distribution of surfactant that was intratracheally administered into rat lungs suffering from ARDS-like injury. Before the in vivo experiments, surfactant distribution was measured in vitro in a twodimensional anatomical glass replica of the first three generations of a human lung's tracheobronchial tree (Fig. 1 , Table 2 ). Previously, the in vitro spreading velocities of Alveofact, BLSE, and BLSE supplemented with Bodipy-labeled SP-B in a square glass tray were found to be equal (27) . In the spreading experiments performed in this study, the three surfactants compared reduced the surface tension to near equilibrium (approximately 25 mN/m) independent of trough geometry. These results demonstrated that BLSE supplemented with Bodipy-labeled SP-B can be used as a marker to investigate surfactant distribution in vivo. BAL, bronchoalveolar lavage; PMN, polymorphonuclear neutrophil. a p Ͻ .05 for LPS-exposed vs. control by means of Mann-Whitney test; b p Ͻ .001 for LPS-exposed vs. control by means of Mann-Whitney test; c No statistically significant difference between LPSexposed and control rats found by means of Mann-Whitney test.
Intratracheal aerosolization of LPS was chosen as a model for ARDS, because ARDS frequently occurs in conjunction with sepsis caused by infection with bacteria producing the pathogen LPS. In agreement with Van Helden et al. (22) , this approach resulted in lung damage comparable to that seen in ARDS (Table  3 ). According to Murray et al. (34) , the LPS-exposed rats would have to be classified as having severe lung injury.
The optimal dose of exogenous surfactant for treatment of ARDS patients is unknown. Usually, doses of 50 -200 mg/kg are used in human and animal studies. Although higher doses are considered necessary to overcome inhibitory effects of plasma proteins on surfactant activity, we decided against a high-dose strategy because it was recently shown for LPS-induced lung injury that treatment of rats with Curosurf (62.5 mg/kg) improved lung function and decreased mortality rate (35) . Furthermore, promising results in humans have been obtained at low doses (50 mg/kg) (11, 36, 37) .
When slices of LPS-exposed and surfactant-treated rat lungs were examined by using a fluorescence microscope, fluorescent signals were observed readily at the alveolar level as well as in some airways ( Fig. 4) . Although visualization of labeled SP-B in the alveolar lining layer of thin lung slices is beyond the resolution of a fluorescence microscope, this finding strongly suggests that fluorescently labeled surfactant had entered the most peripheral parts of the lung by spreading along the airway surface. Moreover, the possibility exists that some of the signals observed even may represent fluorescently labeled surfactant taken up by either type II cells or macrophages. This would not disprove our assumption. Instead, it would only add further evidence to our observation that surfactant had reached the alveolus. Based on the half-lives of SP-B in rabbit (38) and mouse lung (39) of 7 hrs and 28 hrs, respectively, we estimate that in our series of experiments, SP-B clearance was Ͻ10% within 1 hr. Because no statistical differences in total fluorescent signals were observed within the observation period of 5-60 mins, it is reasonable to assume that the major portion of the administered SP-B visible by fluorescence microscopy was part of the alveolar lining layer.
Interestingly, fluorescent signals were detected mostly in lung regions representing underinflated (dystelectatic) as well as aerated (open) alveolar areas (Fig.  5 ). In contrast, little fluorescence was detected in regions defined as collapsed (atelectatic) areas. This finding indicates that surfactant instilled into sick lungs known for both their patchy distribution as well as their inhomogeneous extent of tissue damage distributes in a nonuniform rather than in a uniform way. In particular, surfactant appears to spread preferentially into ventilated rather than unventilated lung areas. This is in contrast to Bambang Oetomo et al. (20) , who showed by immunohistochemical localization of SP-C that instilled surfactant predominantly distributed to collapsed alveolar spaces. However, appearance and distribution pattern of SP-C varied substantially among animals. One possible explanation for the disparate result is that the pathologic changes seen in a lung injury model induced by repeated lavage used by Bambang Oetomo et al. (20) (e.g., surfactant depletion, air trapping by foamy liquid) are usually less severe than those seen by aerosolization of LPS used in this study (e.g., evasion of polymorphonuclear leukocytes, high permeability, alveolar edema, surfactant inhibition). In fact, surfactant-depleted lungs easily can be rescued and appropriate gas exchange reinstituted by simple lung volume recruitment maneuvers (40) , indicating that ventilation is quite homogeneously distributed. Therefore, surfactant in lavaged lungs is likely to spread more evenly. Another explanation is that dystelectatic and atelectatic alveoli were not discerned in the study by Bambang Oetomo et al. (20) . This raises the possibility that at least part of the signal attributed to collapsed (atelectatic) alveoli in fact originated from underinflated (dystelectatic) alveolar areas.
Another interesting aspect raised by the inhomogeneous distribution of lung surfactant observed in this study is the possible response of the injured lung to mechanical ventilation. In an attempt to open up the lung and facilitate surfactant spreading, we inflated the lungs three times to 20 mbar over a 3-sec period after surfactant administration. This moderate form of lung volume recruitment was chosen because of ease of application and lack of hemodynamic interference. It also was chosen because the aim of this study was to investigate intrapulmonary surfactant distribution rather than effects of aggressive volume recruitment maneuvers recommended to open severely consolidated lungs (41) (42) (43) . Nevertheless, the results of our study are important for several reasons. First, the results provide evidence that ventilated lung areas receive surfactant ( Fig. 4) and can be expected to respond to and benefit from moderate recruitment maneuvers and appropriate mechanical ventilation between upper and lower inflection points of the respiratory pressure-volume curve. With regard to the underinflated lung areas, the decrease in surface tensile force will move these areas out of the flatter part toward the steep part of the pressurevolume curve. Therefore, this method might help protect against shear stress, prevent alveolar collapse, and avoid propagation of ventilator-induced lung injury (44) . With regard to the aerated lung areas, the decrease in surface tensile force will move them toward the more flat portion of the inspiratory pressure-volume curve. Therefore, application of excessively high transpulmonary pressures will tend to overdistend aerated lung units and increase their risk for barotrauma. However, if transpulmonary pressures larger than 30 -35 cm of water are avoided, aerated lung areas should not be overdistended (45) and the risk for barotrauma should be negligible. In fact, surfactant replacement might even help reduce occurrence of pneumothorax (46) . In our series of experiments, no pneumothorax occurred. Second, in our study, only small amounts of exogenously administered surfactant reached collapsed areas. This finding was independent of length of mechanical ventilation (up to 60 mins). It suggests that atelectatic lung units cannot readily benefit from surfactant replacement therapy unless these structures are opened up and conditioned such that an air-water interface is formed before surfactant instillation. In contrast to aerated and underinflated lung regions, such collapsed areas might benefit from aggressive lung volume recruitment maneuvers aimed at opening the alveoli up and keeping them open (41) (42) (43) . If such an approach appears too invasive, body positioning could be considered as an alternative. A case report recently showed by quantitative analysis of CT that conditioning of the lungs by changes in body positioning before surfactant replacement helped improve gas exchange by expanding underinflated and collapsed lung areas (47) .
Finally, intrapulmonary surfactant distribution thus far has been investigated only on a macroscopic scale (small pieces of lung) (17-21) but not on a microscopic scale (alveolus). Moreover, the results were inconclusive. Although some authors (19, 21) found that exogenous surfactant spread homogeneously throughout the entire lung, other groups (17, 18) observed a more inhomogeneous distribution. These results, when compared with those obtained in our study, may be different for various reasons. First, markers used in those studies either were not derived from natural surfactant components or were added to surfactant without knowledge of the components to which the label was attached (17) (18) (19) 21) . Second, we found that the boundary between open and atelectatic lung areas can be as small as a few alveoli. Consequently, homogenization of lung lobes or pieces will not allow a sufficiently detailed analysis of a particular lung area.
CONCLUSION
Direct observation of a natural component of lung surfactant is a valuable approach to study surfactant distribution. The results obtained in this study suggest that exogenous surfactant instilled into lungs with ARDS-like injury distributes preferentially into underinflated (dystelectatic) and aerated (open) lung areas. Therefore, these lung regions might benefit the most from surfactant replacement therapy. Furthermore, we have shown that when conventional mechanical ventilation is used, instilled surfactant in general cannot reach collapsed (atelectatic) alveolar areas in sufficiently large amounts. Therefore, collapsed regions will not readily benefit from surfactant therapy unless they are opened up before surfactant administration. 
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